#Canada #FDA Approval #Toronto #Xtalks #Drug Compendia

Upcoming Webinar: Strategic Use of Drug Compendia

In the ever-evolving landscape of healthcare, particularly in the realm of pharmaceuticals, understanding the complexities of payer coverage and FDA approvals is crucial. Xtalks is hosting a free webinar titled "Drug Compendia: Practical Strategies to Bridge Evidence and Payer Coverage" on November 7, 2025. This session promises to enlighten attendees on the pivotal role drug compendia play in connecting FDA-sanctioned medications with payer coverage, especially in situations involving off-label use.

The Role of Drug Compendia

Since their recognition by the Centers for Medicare & Medicaid Services (CMS) in 1993, drug compendia have served as an essential resource. They provide a validated basis for supporting off-label use and facilitating reimbursement for therapeutic products. Many healthcare providers and organizations often misconstrue off-label prescriptions as illegal or unsafe. However, this free educational resource aims to clarify such misconceptions and demonstrate the legitimacy and value of drug compendia.

The featured speakers during the webinar, including notable experts from Avalere Health, are dedicated to demystifying the function of compendia in the healthcare framework. These professionals will cover how compendia act as independent validators, contributing to medical necessity and supporting provider decisions on patient care. By participating in this webinar, attendees will gain critical insights into optimizing their approach to payer interactions and successfully navigating the regulatory environment.

Understanding Off-Label Use

One of the core discussions during the webinar will center around off-label use cases. Attendees will learn about the historical context and regulatory backing for such practices. Given the rapid pace of innovation in drug development, it's common for clinical pathways to evolve faster than regulatory approvals. This is particularly relevant for small or emerging life sciences companies that might be pioneering new therapies.

By leveraging compendia strategically, these companies can enhance their visibility among payers, demonstrate clinical necessity, and ultimately improve patient access to essential treatments. Factors identified as critical for success include the availability of supporting clinical guidelines, real-world evidence, and timely submission of data to compendia.

Case Studies and Practical Insights

The webinar will showcase case studies, illustrating how various companies have benefited from incorporating drug compendia in their strategy. A spotlight on a real-world client experience will provide attendees with actionable insights into navigating complex payer environments and enhancing drug access. There’s a particular emphasis on thinking beyond traditional FDA approval timelines and recognizing the simultaneous push for inclusion in compendia to bolster coverage efforts.

Attendees will hear from:

• - Amy Schroeder – Principal Research Scientist at Avalere Health.
• - Dr. Laura T. Housman, DrPH, MBA, MPH – Chief Public Health Officer, Senior VP, Practice Director at Avalere Health.
• - Mina Allo – Managing Director of Market Access.

Join the Conversation

This insightful session is particularly beneficial for stakeholders in the life sciences, including policymakers, healthcare providers, payers, and manufacturers. By offering a platform that discusses key issues from industry thought leaders, Xtalks enriches knowledge and transforms it into tangible strategies for commercial success.

Register now for this must-attend webinar scheduled for November 7, 2025, at 11 AM EST to learn how you can leverage drug compendia for better patient access and coverage. For more details and registration, visit the official webpage.

With such insightful discussions lined up, this webinar is an excellent opportunity not to be missed for anyone involved in the drug development and healthcare ecosystem.

About Xtalks

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational content geared towards the global life sciences industry, including pharmaceuticals, biotechnology, and healthcare. Delivering quality webinars and digital media, Xtalks remains a go-to resource for professionals looking to stay informed of industry trends and regulatory developments.